Fifteen patients with advanced carcinoma of the breast who had failed prior chemotherapy, were treated with recombinant gamma interferon at a dose of 2mg/m2 (1mg = 2.4 X 10(7) international units) intravenously for five consecutive days every other week. The median patient age was 51 and all patient
โฆ LIBER โฆ
Phase II trial of the novel sulphonylurea sulofenur in advanced breast cancer
โ Scribed by Denis C. Talbot; Ian E. Smith; Marianne C. Nicolson; Trevor J. Powles; Diane Button; Jackie Walling
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 388 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Recombinant gamma interferon in advanced
โ
Hyman B. Muss; Mary Caponera; Patricia J. Zekan; Don V. Jackson; John J. Stuart;
๐
Article
๐
1986
๐
Springer US
๐
English
โ 365 KB
Phase II trials with toremifene in advan
โ
Ritva Valavaara
๐
Article
๐
1990
๐
Springer US
๐
English
โ 334 KB
Phase II trial of prednimustine, L-1031,
โ
H. T. Mouridsen; D. Kristensen; J. Halskov Nielsen; P. Dombernowsky
๐
Article
๐
1980
๐
John Wiley and Sons
๐
English
โ 279 KB
๐ 1 views
Phase II trial of amonafide in advanced
โ
Cynthia Gail Leichman; Cathy Tangen; John S. Macdonald; Thomas Leimert; Thomas R
๐
Article
๐
1993
๐
Springer US
๐
English
โ 234 KB
Phase II trial of menogaril in advanced
โ
Eduard E. Holdener; Wim W. Bokkel Huinink; Genevieve Decoster; Christian Ludwig;
๐
Article
๐
1988
๐
Springer US
๐
English
โ 262 KB
Menogaril, a new semisynthetic anthracycline antibiotic, was administered to 35 patients with advanced colorectal cancer. The drug was infused over 2 hr at a dose of 160 mg/sqm or 200 mg/sqm repeated every 4 weeks. Twenty-seven patients were evaluable for response and no objective responses were ach
Phase II trial of piroxantrone in metast
โ
Peter M. Ravdin; Stephanie Green; James H. Doroshow; Silvana Martino
๐
Article
๐
1994
๐
Springer US
๐
English
โ 274 KB